EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 9

Ensembl ID : ENSOPRG00000006904
Gene Symbol: MAP3K9
3 Cross references
194 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSOPRG00000003749
Gene Symbol: NPR1
1 Cross references
184 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSOPRG00000012893
Gene Symbol: NPR2
1 Cross references
259 Possible Orthologues:

Neuropeptide Y Receptor Y4-2

Ensembl ID : ENSOPRG00000010106
Gene Symbol: NPY4R2
2 Cross references
116 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSOPRG00000000693
Gene Symbol: NTRK1
1 Cross references
199 Possible Orthologues:

Nicastrin

Ensembl ID : ENSOPRG00000005767
Gene Symbol: NCSTN
1 Cross references
203 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSOPRG00000010731
Gene Symbol: NAMPT
1 Cross references
235 Possible Orthologues:

Nischarin

Ensembl ID : ENSOPRG00000009121
Gene Symbol: NISCH
1 Cross references
209 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSOPRG00000012596
Gene Symbol: NOS2
1 Cross references
163 Possible Orthologues:

Notch Receptor 3

Ensembl ID : ENSOPRG00000014896
Gene Symbol: NOTCH3
1 Cross references
200 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 3

Ensembl ID : ENSOPRG00000009497
Gene Symbol: NR1H3
3 Cross references
391 Possible Orthologues:

Nuclear Receptor Subfamily 3 Group C Member 2

Ensembl ID : ENSOPRG00000013315
Gene Symbol: NR3C2
1 Cross references
212 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).